Ocufen, also known as flurbiprofen, is a nonsteroidal anti-inflammatory drug (NSAID) commonly used in ophthalmology to reduce inflammation and pain following cataract surgery. It works by inhibiting the production of prostaglandins, which are chemicals in the body that cause inflammation and pain.

This medication is typically administered as eye drops, with a recommended dosage of one drop in the affected eye(s) four times a day for up to three days after surgery. It is important to follow your healthcare provider’s instructions carefully and not to exceed the prescribed dosage.

While Ocufen is generally well-tolerated, some patients may experience mild side effects such as stinging or burning in the eyes, blurred vision, or sensitivity to light. If these symptoms persist or worsen, it is important to contact your healthcare provider.

It is important to inform your healthcare provider of any other medications you are taking, as they may interact with Ocufen and cause unwanted side effects. Additionally, if you have a history of certain medical conditions such as asthma, bleeding disorders, or kidney disease, your healthcare provider may need to adjust your dosage or monitor you more closely while taking this medication.

Overall, Ocufen is a safe and effective medication for reducing inflammation and pain following cataract surgery. By following your healthcare provider’s instructions and reporting any side effects promptly, you can ensure a successful recovery and optimal outcomes from your procedure.